Skip to main content

Table 2 Incidence rates of acute myocardial infarction, ischemic stroke, amputation, and hospitalization for infection after landmark date (the 360th day) and competing events of death for vitamin D users versus non-users, respectively

From: The use of activated vitamin D and risks of hospitalization for infection and amputation in incident hemodialysis patients in Taiwan: a nationwide population-based cohort study

 

Follow-up (person-year)

Event of interest (%)

Event of interest

(per 1000 p-y)

Death (%)a

Crude death rate

(per 1000 p-y)

Total

AMI

Non-user

137,639.35

2364 (5.4)

17.2

16,312 (37.5)

118.5

43,495

Vitamin D user

28,378.86

359 (4.5)

12.6

2340 (29.3)

82.5

8020

All

166,018.21

2723 (5.3)

16.4

18,652 (36.2)

112.3

51,515

Ischemic stroke

Non-user

135,591.67

3045 (7.5)

22.5

15,936 (39.4)

117.5

40,407

Vitamin D user

28,133.93

415 (5.2)

14.8

2312 (28.8)

82.2

8022

All

163,725.60

3460 (6.7)

21.1

18,248 (35.5)

111.5

51,429

Amputation

Non-user

138,462.73

2370 (5.4)

17.1

16,629 (37.7)

120.1

44,105

Vitamin D user

28,735.85

253 (3.1)

8.8

2426 (29.9)

84.4

8109

All

167,198.58

2623 (5.0)

15.7

19,055 (36.5)

113.9

52,214

Infection

Non-user

97,982.67

19,178 (50.4)

195.7

4513 (11.8)

46.1

38,075

Vitamin D user

21,014.29

2904 (41.0)

138.2

759 (10.7)

36.1

7079

All

118,996.96

22,082 (48.9)

185.5

5272 (11.7)

44.3

45,154

  1. aNote: Death is a competing event that precludes the occurrence of events of interest, including AMI, ischemic stroke, amputation, and infection, respectively
  2. Abbreviations: AMI, acute myocardial infarction; p-y, person-year